PRE-CONFERENCE WORKSHOPS
The 2023 APSAD Scientific Advisory Committee is pleased to announce the Pre-Conference Workshops to be held on Sunday 12 November 2023.
More workshop information will be added to this page as it becomes available.
2023 Nicotine Addiction and Smoking Cessation Update Day
Time: |
Sunday 12 November |
Register: |
Workshop Only Registration |
Costs: |
Registration Costs |
Overview: | The annual Nicotine Addiction and Smoking Cessation Update Day is organised by the APSAD Smoking Cessation Professionals Special Interest Group and provides an important avenue for the dissemination and discussion of the latest evidence-based research and best practice approaches in the treatment of nicotine dependence and smoking cessation. The Nicotine Addiction and Smoking Cessation Update Day is open to all workers who are interested in enhancing their knowledge around tobacco cessation, electronic nicotine delivery systems, and the latest evidence-based treatment interventions. The schedule for the workshop can be found here |
2023 Fetal Alcohol Spectrum Disorder Special Interest Group (FASD SIG) Pre-Conference Workshop
Time: |
Sunday 12 November |
Register: |
Workshop Only Registration |
Costs: |
Registration Costs |
Overview: | The Fetal Alcohol Spectrum Disorder Special Interest Group (FASD SIG) Pre-conference event will include a range of different types of sessions across the day including: international keynote speakers, fast research talks focused on new findings, a lived experience panel discussion, and a look at how to support communities and cultural responsiveness in clinical practice guidelines. The day is planned to be an inclusive event open to a wide range of people including, people with lived experience, advocacy groups, community members, researchers, clinicians, and students. Anyone with an interest in FASD is welcome to attend! The schedule for the workshop can be found here |
Causal Inference in Addiction Research Pre-Conference Workshop
Time: |
Sunday 12 November |
Register: | |
Costs: |
Registration Costs |
Overview: | Randomised controlled trials (RCTs) are the gold standard for causal inference. Randomisation removes all confounding and allows the treatment effect to be isolated. However, RCTs are conducted under tightly controlled environments and may have limited generalisability. They are also often not feasible in addiction research due to ethical or logistical reasons. Observational data from real-world settings are increasingly used to guide public health and clinical decisions. In this workshop, we will provide an overview of modern approaches to designing observational study that enable causal inferences. We will firstly cover three key techniques: Directed Acyclic Graphs (DAGs), modified Disjunctive Cause Criterion, Target Trial Emulation. We will then provide an overview on the counterfactual framework for causal inference and propensity score matching. We will illustrate these techniques using examples in addiction research and discuss the strength and limitations in their applications in addiction research. Schedule 9.00-10.30 Introduction to Directed Acyclic Graphs (DAGs) and the Disjunctive Cause Criterion 10.30-10.50 Morning tea 10.50- 11.15 Introduction to Target Trial Emulation 11.15- 11.25 Q&A 11.25 – 1.00 Introduction to the counterfactual framework and Propensity Score Matching. |
NCCRED Symposium
Time: |
Sunday 12 November |
Register: | You can register for the NCCRED Symposium during registration for the conference |
Costs: |
Registration Costs |
Overview: | The 5th annual Symposium for the National Centre for Clinical Research on Emerging Drugs (NCCRED) will be held on Sunday 12th November 2023 in Riverbank Room 5, at the Adelaide Conference Centre from 12pm – 6pm. Key themes of the 2023 symposia will include knowledge translation, digital interventions and prompt responses to emerging drugs of concern.
NCCRED’s 2023 symposium will be a vital networking opportunity for all people interested in driving new ways to reduce the harms from methamphetamine and other drugs of emerging concern in Australia. |